GlassScriptPhysician profile
Rolf W Knoll
NPI 1881696193
$696.69
in general payments reported to CMS, 2019-2025
16 companies · $15.19 in 2025
The $15.19 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $542 · 2020: $139 · 2025: $15.19.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $15.19.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $15.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $110.28 | 2019-2020 | |
| Pfizer INC. | $84.73 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $72.72 | 2019-2020 | |
| Amarin Pharma, INC. | $56.03 | 2019 | |
| Amgen INC. | $53.23 | 2019-2020 | |
| Astellas Pharma US INC | $45.75 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $45.31 | 2019-2020 | |
| Lilly USA, LLC | $35.92 | 2020 | |
| Glaxosmithkline, LLC. | $33.92 | 2019 | |
| Sanofi-Aventis U.S. LLC | $31.55 | 2019 | |
| Merck Sharp & Dohme LLC | $30.85 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.87 | 2020 | |
| Mdd US Operations, LLC | $22.66 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.53 | 2019 | |
| Circassia INC. | $17.15 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kowa Pharmaceuticals America, INC. | $15.19 | 2025 | Zoryve |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rolf Knoll listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.